Common name
prop-1-ene
IUPAC name
prop-1-ene
SMILES
CC=C
Common name
prop-1-ene
IUPAC name
prop-1-ene
SMILES
CC=C
INCHI
InChI=1S/C3H6/c1-3-2/h3H,1H2,2H3
FORMULA
C3H6
Common name
prop-1-ene
IUPAC name
prop-1-ene
Molecular weight
42.080
clogP
0.442
clogS
-0.470
Frequency
0.0299
HBond Acceptor
0
HBond Donor
0
Total PolarSurface Area
0
Number of Rings
0
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD01007 | Dinoprost Tromethamine |
|
Oxytocics; Abortifacient Agents, Nonsteroidal; Angiography; Stimulants, Uterine; Tromethamine; | Used for aborting second-trimester pregnancy (between the twelfth to eighteenth week of gestation) and in incomplete abortion or for therapeutic abortion in cases of intrauterine fetal death and congenital abnormalities incompatible with life. Also used at low-doses for medically indicated induction of labor at term. Also injected intra-arterially for use as a vasodilator to assist in angiography. |
| FDBD01029 | Naloxone |
|
Narcotic Antagonists; Antidotes; Central Nervous System Depressants; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; | For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol. It is also indicated for the diagnosis of suspected acute opioid overdose. It may also be used as an adjunctive agent to increase blood pressure in the management of septic shock. |
| FDBD01151 | Aprobarbital |
|
Hypnotics and Sedatives; Nervous System; Psycholeptics; Barbiturates, Plain; | |
| FDBD01200 | Alizapride |
|
Antiemetics; Prokinetic Agents; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Propulsives; | Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. |
| FDBD01205 | Almitrine |
|
Respiratory System Agents; Respiratory System; Respiratory Stimulants; | For the treatment of chronic obstructive pulmonary disease. |
| FDBD01206 | Allylestrenol |
|
Progestins; Sex Hormones and Modulators of the Genital System; Genito Urinary System and Sex Hormones; Progestogens; Estren Derivatives; CYP3A4 Inhibitors; | Allylestrenol was designed to be used for miscarriage prevention, prevention of premature labour and has been investigated for possible use in men for treatment for benign prostatic hyperplasia. |
| FDBD01233 | Oxprenolol |
|
Anti-Anxiety Agents; Antihypertensive Agents; Sympatholytics; Anti-Arrhythmia Agents; Vasodilator Agents; Adrenergic beta-Antagonists; Cardiovascular System; Beta Blocking Agents; Beta Blocking Agents and Thiazides; Beta Blocking Agents, Non-Selective; Beta Blocking Agents, Non-Selective, and Thiazides; CYP2D6 Inducers; CYP2D6 Inducers (strong); | Used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. |
| FDBD01305 | Oleic Acid |
|
; | |
| FDBD01326 | Flunarizine |
|
Anticonvulsants; Vasodilator Agents; Calcium Channel Blockers; Histamine H1 Antagonists; Nervous System; Antivertigo Preparations; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); | Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. |
| FDBD01330 | Ixabepilone |
|
Antineoplastic Agents; Antineoplastic and Immunomodulating Agents; Cytotoxic Antibiotics and Related Substances; CYP3A4 Inhibitors; | Investigated for use/treatment in breast cancer, head and neck cancer, melanoma, lung cancer, lymphoma (non-hodgkin's), prostate cancer, renal cell carcinoma, and cancer/tumors (unspecified). |
87 ,
9
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 3dzt_ligand_1_8.mol2 | 3dzt | 1 | -5.96 | C(=C)C | 3 |
| 2a2g_ligand_frag_1.mol2 | 2a2g | 1 | -5.91 | C(=C)C | 3 |
| 3dzt_ligand_1_9.mol2 | 3dzt | 1 | -5.91 | C=CC | 3 |
| 1o6h_ligand_1_0.mol2 | 1o6h | 1 | -5.89 | C=CC | 3 |
205 ,
21
